Previous issues
Volume 25 Issue 1
-
Reviews
Recent research trends and updates on nonalcoholic fatty liver disease
- Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn
- Clin Mol Hepatol. 2019;25(1):1-11.
-
Pathologic differential diagnosis of metastatic carcinoma in the liver
- Jeong Hwan Park, Jung Ho Kim
- Clin Mol Hepatol. 2019;25(1):12-20.
-
Radiomics and radiogenomics of primary liver cancers
- Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu
- Clin Mol Hepatol. 2019;25(1):21-29.
-
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
- Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
- Clin Mol Hepatol. 2019;25(1):30-36.
-
Editorials
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
- Young Woo Eom, Soon Koo Baik
- Clin Mol Hepatol. 2019;25(1):37-39.
-
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
- Won Kim
- Clin Mol Hepatol. 2019;25(1):40-41.
-
Original Articles
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
- Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
- Clin Mol Hepatol. 2019;25(1):42-51.
-
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
- Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
- Clin Mol Hepatol. 2019;25(1):52-64.
-
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
- Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
- Clin Mol Hepatol. 2019;25(1):65-73.
-
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
- Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
- Clin Mol Hepatol. 2019;25(1):74-85.
-
Letter to the Editor
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
- Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim
- Clin Mol Hepatol. 2019;25(1):86-91.